Gartland Type 3 Supracondylar FractureNCT07266038
Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type 3 Supracondylar Fractures of Children
A study testing Cross K Wire Fixation and Lateral K wire Fixation in people with Gartland Type 3 Supracondylar Fracture, run by Laiba Qamar at 1 site in Pakistan.
Trial summary
This study compares the efficacy of K wire when inserted in Cross V/s Lateral Direction in Supracondylar fractures of Gartland Type 3 in children. A comparative study. Read more about this study
- Who is it for?
- Ages 2 to 13 years
- Conditions the study is for
- Gartland Type 3 Supracondylar Fracture
- What is being tested?
- Cross K Wire Fixation and Lateral K wire Fixation
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 90 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Jul 2024to 31 Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 2 to 13 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- All male and female patients of age 02-13 years with Gartland type 3 Supracondylar Fracture of Humerus less than 7 days old
Who cannot join
- patients with open fractures patients with neurovascular injuries patients with medial column communition Fractures more than 7 Days old Ipsilateral fractures of radius/ulna or shaft of humerus pathological fractures which are associated with bone density changes
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Bahawal Victoria Hospital
Bahawalpur, Punjab Province, 16300
Shahid Mahmood Dr, MBBS, FCPS, FRCS, +92 3238092608, dr.shahidortho@hotmail.com
About this study
Official title: Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type # Supracondylar Fractures of Children : A Comparative Study
This study compares the efficacy of K wire when inserted in Cross V/s Lateral Direction in Supracondylar fractures of Gartland Type 3 in children. A comparative study.
Read the detailed description
This is a randomized control trial being done to compare the efficacy of Cross V/S Laterally Placed K wire In Supracondylar fractures to calculate and copmpare the Post K wire iinsertion range of motion . It is also intended to calculate the frequency of loss of reduction after lateral K wire in terms of Skaggs Criteria . This study intends to find the better method of K wire fixatio to avoid the post fixation loss of reduction.
- Conditions
- Gartland Type 3 Supracondylar Fracture
- Being tested
- Cross K Wire Fixation, Lateral K wire Fixation
- Keywords
- K-wire, supracondylar Frcature, Fixation, Loss of reduction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cross K Wire FixationProcedure or surgery
In this intervention the K wire will be fixed in a Manner of Cross at the site of frature.
Lateral K wire FixationProcedure or surgery
In this arm of intervention the K wire will be fixed laterally at the site of fracture.
| Study group | Role | What they receive |
|---|---|---|
| Group A | Active comparator | The participants enrolled in this arm will be treated with cross K wire fixation Receives: Procedure: Cross K Wire Fixation |
| Group B | Experimental | The participants enrolled in this arm will be treated with lateral fixation of K wire after supracondylar fracture. Receives: Procedure: Lateral K wire Fixation |
What is being measured
The primary outcome is the main question the study is designed to answer.
frequency of post K wire fixation loss of reduction
It is comonly noted that after lateral K wire fixation there is more frequent loss of reduction as compared to cross fixation method. The frequency of loss of reduction will be noted after the intervention.
Measured: 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2025
- Study start1 Jul 2024
- Primary completion31 Dec 2025 (estimated)
- Study completion31 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gartland Type 3 Supracondylar FractureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 90 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Laiba Qamar
- Sponsor type
- University, hospital or other
- Collaborators
- Bahawal Victoria Hospital Bahawalpur
- Responsible party
- Sponsor-investigator, Laiba Qamar, University of Health Sciences Lahore
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07266038
- Sponsor's protocol ID
- #CVSLKWIRE3#
- Status last verified
- Nov 2025
- First submitted
- 24 Nov 2025
- Last updated
- 5 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Cross K-wire Vs Lateral Entry K-wire Fixation in Maintaining Reduction of Gartland Type # Supracondylar Fractures of Children : A Comparative Study
- ClinicalTrials.gov ID
- NCT07266038
- Acronym / sponsor ID
- #CVSLKWIRE3#
- Conditions
- Gartland Type 3 Supracondylar Fracture
- Keywords
- K-wire, supracondylar Frcature, Fixation, Loss of reduction
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 90 participants (estimated)
- Lead sponsor
- Laiba QamarUniversity, hospital or other
- Collaborators
- Bahawal Victoria Hospital Bahawalpur
- Study start
- 1 Jul 2024 (actual)
- Primary completion
- 31 Dec 2025 (estimated)
- Study completion
- 31 Dec 2025 (estimated)
- First posted
- 5 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study compares the efficacy of K wire when inserted in Cross V/s Lateral Direction in Supracondylar fractures of Gartland Type 3 in children. A comparative study.
Detailed description
This is a randomized control trial being done to compare the efficacy of Cross V/S Laterally Placed K wire In Supracondylar fractures to calculate and copmpare the Post K wire iinsertion range of motion . It is also intended to calculate the frequency of loss of reduction after lateral K wire in terms of Skaggs Criteria . This study intends to find the better method of K wire fixatio to avoid the post fixation loss of reduction.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A | Active comparator | Procedure: Cross K Wire FixationThe participants enrolled in this arm will be treated with cross K wire fixation |
| Group B | Experimental | Procedure: Lateral K wire FixationThe participants enrolled in this arm will be treated with lateral fixation of K wire after supracondylar fracture. |
Who may qualify
- Ages
- 2 to 13 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (1 listed)
- All male and female patients of age 02-13 years with Gartland type 3 Supracondylar Fracture of Humerus less than 7 days old
Key exclusion criteria (1 listed)
- patients with open fractures patients with neurovascular injuries patients with medial column communition Fractures more than 7 Days old Ipsilateral fractures of radius/ulna or shaft of humerus pathological fractures which are associated with bone density changes
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cross K Wire FixationIn this intervention the K wire will be fixed in a Manner of Cross at the site of frature. | Procedure or surgery | Group A |
| Lateral K wire FixationIn this arm of intervention the K wire will be fixed laterally at the site of fracture. | Procedure or surgery | Group B |
Primary outcome
frequency of post K wire fixation loss of reduction
Time frame: 2 months
It is comonly noted that after lateral K wire fixation there is more frequent loss of reduction as compared to cross fixation method. The frequency of loss of reduction will be noted after the intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Dec 2025.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cross K Wire Fixation and Lateral K wire Fixation in people with Gartland Type 3 Supracondylar Fracture, run by Laiba Qamar at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 5 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact M Junaid Khan Dr, MBBS (+92 307 5681857, junikhan111@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
frequency of post K wire fixation loss of reduction (time frame: 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2025.